Search details
1.
Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
Ann Surg Oncol
; 30(7): 4087-4094, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36905438
2.
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Mod Pathol
; 33(11): 2221-2232, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32612248
3.
ASO Visual Abstract: Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
Ann Surg Oncol
; 30(7): 4095-4096, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37022571
4.
Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
Ann Surg Oncol
; 25(1): 154-163, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29094250
5.
Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
Int J Surg Pathol
; 25(2): 100-107, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-27481892
6.
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival.
PLoS One
; 9(12): e114900, 2014.
Article
in English
| MEDLINE | ID: mdl-25506917
Results
1 -
6
de 6
1
Next >
>>